The CD9+ S‐EVs were more abundant in AdvPCa samples (4.91E+08 particle/ml, Figure 1b) and significantly higher than CD9+ S‐EVs from BPH patients (**P < 0.01) and LPCa (***P < 0.001). The gene discussed is CD9; the disease is benign prostatic hyperplasia.